Avalyn Pharmaceuticals

Develops improved therapies for idiopathic pulmonary fibrosis (IPF) and other respiratory diseases.
Develops improved therapies for idiopathic pulmonary fibrosis (IPF) and other respiratory diseases.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Seattle, WA

Initial Investment

2017
Avalyn Pharmaceuticals

Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases.